Phase 4 Type 2 Diabetes Trial, Recruiting NCT05780905 Sponsor: University of Washington Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Phase 4 Type 2 Diabetes Trial, Recruiting

NCT05780905
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 40 and 65 years old (male or female)
  • You have had type 2 diabetes for at least 3 years, with a blood sugar control level (HbA1C) between 7% and 10%, and you are already taking diabetes medications such as insulin, metformin, sulfonylureas, or SGLT2 inhibitors
  • You are in a generally stable state of health
  • You have not taken part in a study using an experimental drug in the past 6 months
  • You are willing to take part and sign a consent form

Who may not be able to join:

  • You have a reason you cannot have an MRI scan or receive the contrast dye used during MRI (confirm with trial site)
  • Your kidney function is below a certain level (specifically, eGFR below 45 — a measure of how well your kidneys are working)
  • You are currently taking a medication in the same drug class as the one being studied, such as semaglutide, liraglutide, or similar GLP-1 medications
  • You are unable to check your own blood sugar levels at home
  • You currently need more than 100 units of insulin per day
  • Your blood pressure is very high and uncontrolled (top number above 180 or bottom number above 100)
  • Your LDL ("bad") cholesterol is above 130 mg/dL, or you have not been on a stable cholesterol-lowering (statin) medication for at least the past 6 months
  • You have taken the diabetes medication pioglitazone in the past 3 months
  • You have a history of pancreatitis (inflammation of the pancreas)
  • You have had a heart attack, stroke, or mini-stroke (TIA) in the past
  • You or a close family member have a history of a specific type of thyroid cancer (Medullary Thyroid Carcinoma) or a related condition called Multiple Endocrine Neoplasia type 2
  • You have had an allergic reaction to semaglutide or any of its ingredients
  • You are currently participating in another clinical trial
  • You are a woman who could become pregnant, and you are currently pregnant, breastfeeding, or plan to become pregnant within the next 15 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Francis Kim, MD, University of Washington

Phone: 206-744-8305

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Registry
ClinicalTrials.gov
Start date
11 January 2024
Est. completion
31 March 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Intracranial blood flow (IBF); bloodbrain barrier Ktrans

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov